Also trades as: 0QZU.L (LSE) · $vol 1M · VX1.DE (XETRA) · $vol 0M

$434.52

+0.98 (+0.23%)

Weekly Expected Move ±3.1%

$410 $423 $437 $450 $463

NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 50 · $110.3B mcap · 253M float · 0.505% daily turnover · Short 35% of daily vol

Revenue

$12.1B +9.6% ▲

5Y CAGR: +14.2%

Gross Profit

$10.3B +8.2% ▲

5Y CAGR: +13.4%

Operating Income

$4.8B +2144.1% ▲

5Y CAGR: +10.8%

Net Income

$4.0B +838.1% ▲

5Y CAGR: +7.8%

EPS (Diluted)

$15.32 +836.5% ▲

5Y CAGR: +8.3%

EBITDA

$5.0B +921.6% ▲

5Y CAGR: +8.6%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$7.6B	$8.9B	$9.9B	$11.0B	$12.1B
YoY Growth	+22.1%	+17.9%	+10.5%	+11.7%	+9.6%
Cost of Revenue	$904M	$1.1B	$1.3B	$1.5B	$1.8B
Gross Profit	$6.7B	$7.9B	$8.6B	$9.5B	$10.3B
Gross Margin	88.1%	87.9%	87.2%	86.1%	85.0%
R&D Expenses	$3.1B	$2.7B	$3.2B	$3.6B	$3.8B
SG&A Expenses	$840M	$945M	$1.1B	$1.5B	$1.8B
Operating Expenses	$3.9B	$3.5B	$4.8B	$9.7B	$5.5B
Operating Income	$2.8B	$4.3B	$3.8B	-$233M	$4.8B
Operating Margin	36.7%	48.2%	38.8%	-2.1%	39.4%
Interest Expense	$62M	$55M	$44M	$31M	$13M
Income Before Tax	$2.7B	$4.2B	$4.4B	$248M	$4.6B
Tax Expense	$388M	$910M	$760M	$784M	$690M
Net Income	$2.3B	$3.3B	$3.6B	-$536M	$4.0B
Net Margin	30.9%	37.2%	36.7%	-4.9%	32.7%
EPS (Diluted)	$9.01	$12.82	$13.89	$-2.08	$15.32
EBITDA	$2.9B	$4.4B	$4.6B	$486M	$5.0B
Shares Outstanding	260M	259M	260M	258M	258M

Line Item	FY2024 Q2	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1
Revenue	$2.6B	$2.8B	$2.9B	$2.8B	$3.0B	$3.1B	$3.2B	$3.0B
Cost of Revenue	$372M	$393M	$423M	$363M	$408M	$415M	$466M	$393M
Gross Profit	$2.3B	$2.4B	$2.5B	$2.4B	$2.6B	$2.7B	$2.8B	$2.6B
Gross Margin	85.9%	85.8%	85.5%	86.9%	86.3%	86.5%	85.6%	86.8%
R&D Expenses	$5.4B	$876M	$999M	$980M	$978M	$1.0B	$974M	$962M
SG&A Expenses	$372M	$372M	$378M	$396M	$425M	$445M	$487M	$494M
Operating Expenses	$5.8B	$1.3B	$1.5B	$1.8B	$1.4B	$1.5B	$1.5B	$1.5B
Operating Income	-$3.5B	$1.1B	$1.0B	$630M	$1.2B	$1.2B	$1.3B	$1.1B
Operating Margin	-132.9%	40.3%	35.2%	22.7%	38.8%	38.6%	40.3%	38.1%
Interest Expense	$10M	$8M	$3M	$3M	$4M	$3M	$3M	$0
Income Before Tax	-$3.4B	$1.2B	$1.1B	$730M	$1.3B	$1.3B	$1.3B	$1.3B
Tax Expense	$202M	$179M	$224M	$84M	$250M	$216M	$140M	$222M
Net Income	-$3.6B	$1.0B	$913M	$646M	$1.0B	$1.1B	$1.2B	$1.0B
Net Margin	-135.8%	37.7%	31.4%	23.3%	34.8%	35.2%	36.9%	34.5%
EPS (Diluted)	$-13.92	$4.01	$3.50	$2.49	$3.99	$4.20	$4.65	$4.02
EBITDA	-$3.3B	$1.3B	$1.2B	$782M	$1.3B	$1.4B	$1.4B	$1.1B
Shares Outstanding	258M	261M	260M	260M	259M	258M	256M	256M

VRTX NASDAQ